Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2018
DOI: 10.4155/bio-2018-0047
|View full text |Cite
|
Sign up to set email alerts
|

Immunogenicity Testing of Therapeutic Antibodies in Ocular Fluids after Intravitreal Injection

Abstract: The IC assay allows a reliable ADA detection in matrices with high drug concentrations, such as ocular fluids.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
17
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 17 publications
(17 citation statements)
references
References 29 publications
0
17
0
Order By: Relevance
“…Demonstration of ADA in patient's serum who took intra-vitreal anti-VEGF injections was attributed to be in response to the molecules which entered systemic circulation via aqueous drainage pathways. Intra-vitreal presence of these ADA have now been established and confirms presence of adaptive immunity in the eye in certain pathologies like AMD [14].…”
mentioning
confidence: 55%
“…Demonstration of ADA in patient's serum who took intra-vitreal anti-VEGF injections was attributed to be in response to the molecules which entered systemic circulation via aqueous drainage pathways. Intra-vitreal presence of these ADA have now been established and confirms presence of adaptive immunity in the eye in certain pathologies like AMD [14].…”
mentioning
confidence: 55%
“…In contrast, an increased dynamic range would be beneficial because samples would not require high dilutions to be in the assay range. In addition, lower sample consumption of the Ella platform (2.5 vs 25 μl in ELISA) would reduce the difference in sensitivity for samples with limited availability such as mouse samples or rare sample matrices like eye, synovial or cerebrospinal fluids [1][2][3][4]. For example, if only 2.5 μl is available, the sensitivity of the Ella assay would be still 15 ng/ml, whereas the sensitivity of ELISA would be decreased to 19 ng/ml.…”
Section: Resultsmentioning
confidence: 99%
“…Hurdles with poor drug tolerance and related false-negative results with state-of-the-art bridging assays to detect ADA in ocular fluid samples have recently been overcome with more sensitive immune complex assays. 47 Immune complex assays of VH and AH samples with high residual drug concentrations following intravitreal injection in minipigs and monkeys detected ADA, although systemic ADA were detected earlier than in ocular fluids and systemic ADA response was not always accompanied by the presence of ADA in ocular fluids, indicating systemic ADA detection is adequate in most cases for ocular toxicity studies. Aqueous humor was a good predictive matrix for ADA detection in VH, which is important for ease of sampling in AH compared to VH in ocular toxicity studies and minimizing potential contamination issues in VH.…”
Section: Systemic In-life Parametersmentioning
confidence: 96%
“…Recent publications with relevance to ocular toxicity studies in minipigs, primarily Göttingen minipigs, include basic ocular histomorphometry, 41 pre- and postnatal development of the eye, 42 ocular immunohistochemistry and in situ hybridization biomarkers, 43 electroretinography (ERG), 44 and optical coherence tomography (OCT). 43,45 Immunology 46 and ocular immunogenicity testing 47 of minipigs has been characterized, and although the minipig may be suitable for biologics, this species can mount a substantial immunogenic response to human proteins. 13 Vitreous volume in the Gottingen minipig eye using a frozen eye collection technique by Struble et al 48 was approximately 2.3 mL, which is important for calculating a human equivalent dose (HED) and corresponding ocular dose safety margins for intravitreal drugs in this species.…”
Section: Ocular Toxicity Studies: Selecting a Cro Study Designs Andmentioning
confidence: 99%